Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,389.3
-63.7 (-2.60%)

 

  • STI Straits Times Index
    2,389.3
    -63.7 (-2.60%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,330.7
    -0.2 (-0.02%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,236.1
    -44.0 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,764.0
    -16.7 (-0.60%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    17,820.2
    1.5 (0.01%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,623.4
    91.7 (2.02%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,324.3M
  • Value: 1,512.2M
  • Rise: 65
  • Fall: 270
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.095-0.001
ESR-REIT0.250-0.015
Genting Sing0.650-0.015
Mapletree Com Tr1.500-0.120
CapitaMall Trust1.520-0.100
Interra Resource^0.042+0.001
Singtel2.580-0.040
Medtecs Intl0.095+0.005
AusGroup^0.021-0.003
JCG Investment0.002-

World Indices

World Indices
Name Last Change
Nasdaq 7,373.1 -114.2
HSI 23,236.1 -44.0
HSCEI 9,491.1 -35.5
Jakarta 4,623.4 +91.7
Nikkei 225 17,820.2 +1.5
SSE Comp 2,764.0 -16.6
Shanghai A 2,896.6 -17.5
Shanghai B 216.0 -0.8
KOSPI 1,725.4 +0.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FIBROGEN INC FIBROGEN
Updated on 02 Apr 2020 (End of trading day)
Last (USD): 34.040 Change: +1.250 High: 34.100 Remarks: -
Change (%): +3.81 Low: 32.120
Open 32.310 Yesterday's Close 32.79
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 594,870 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.98205 Trailing EPS (USD) e -0.87466 NAV (USD) b 5.8652
PE a - Trailing PE f - Price / NAV b 5.8037
Dividend (USD) d - Cash In Hand (USD) g 1.4348 Issued & Paid-up Shares c 88,000,000
Dividend Yield (%) d - Price / Cash In Hand g 23.725 Treasury Shares h -
Beta - 75 Daysi 1.328 R-Squared - 75 Days(%)i 67.07 Market Cap (M) 2,995.520
Beta - 500 Daysi 0.790 R-Squared - 500 Days (%)i 13.54 Enterprise Value (M) 2,544.641
Piotroski F Score 1 Exchange Code FGEN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 64.19 Free Float (%) 90.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FIBROGEN INC NASDAQ 2,995.520 - - 5.8037 -
Industry Biotechnology NASDAQ 2,280.431 260.327 248.909 5.4913 0.802
Local Peer AMGEN INC NASDAQ 123,198.886 14.677 15.710 12.7364 2.698
Local Peer GILEAD SCIENCES INC NASDAQ 96,918.590 17.767 17.995 4.3027 3.016
Local Peer VERTEX PHARMACEUTICAL NASDAQ 62,784.581 29.949 53.352 10.3175 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,872.460 22.448 25.935 4.9481 -
Local Peer BIOGEN INC NASDAQ 52,997.266 11.961 9.000 3.9719 -
Local Peer ILLUMINA INC NASDAQ 40,129.530 48.583 40.049 8.6992 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,442.094 - - 10.8950 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 20,066.735 258.594 8.346 1.7803 -
Local Peer INCYTE CORPORATION NASDAQ 16,706.926 152.584 37.384 6.4297 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 15,484.432 - - 4.9592 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 12,906.050 - - 29.4748 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 12,316.258 - 39.684 4.4560 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALKERMES PLC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), KODIAK SCIENCES INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARVINAS INC (NASDAQ), EPIZYME INC (NASDAQ), INSMED INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NEXTCURE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NOVAVAX INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), RETROPHIN INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), IMMUNOGEN INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), COMPUGEN (NASDAQ), TRANSLATE BIO INC (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PRECIGEN INC (NASDAQ), AVROBIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), KURA ONCOLOGY INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), XBIOTECH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), PERSONALIS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), GERON CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CABALETTA BIO INC (NASDAQ), IVERIC BIO INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), INFLARX N V (NASDAQ), VAXART INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CHIMERIX INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CONTRAFECT CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMV INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ARAVIVE INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VERMILLION INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), OTONOMY INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), COHBAR INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), RESTORBIO INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INMUNE BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TOCAGEN INC (NASDAQ), CURIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), OCUGEN INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 138,080.841 51.467 47.667 15.9660 0.872
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 22,384.671 70.838 29.299 4.6173 0.847
Global Peer WUXI BIO HKEx 145,043.916 194.191 126.359 10.1425 -
Global Peer SINO BIOPHARM HKEx 132,595.044 12.375 43.078 3.8100 0.694
Global Peer BEIGENE HKEx 80,435.200 - - 10.7286 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,965.560 47.298 54.314 2.7244 -
Global Peer GENSCRIPT BIO HKEx 22,292.636 134.071 - 7.4741 -
Global Peer 3SBIO HKEx 20,446.758 13.516 18.626 1.8991 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), KADMON HLDGS INC (NYSE), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), UNI-BIO GROUP (HKEx), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), AIM IMMUNOTECH INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), BIOSINO BIO-TEC (HKEx), IMMUTEP LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANTEOTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), REGENT PACIFIC (HKEx), Suntar Eco-City^ (SGX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIONOMICS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HAO WEN HLDGS (HKEx), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), LEAF RESOURCES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), ADALTA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.570
+1.70 %
10 Days -+9.170
+36.87 %
20 Days --5.670
-14.28 %
Medium Term Return 3 Months --9.050
-21.00 %
6 Months --2.720
-7.40 %
1 Year --19.980
-36.99 %
Long Term Return 2 Years --10.860
-24.19 %
3 Years -+7.890
+30.17 %
5 Years -+4.140
+13.85 %
Annualised Return Annualised --
+2.63 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 22.650 - 55.635 Change From 1 Year Low +11.390 % Change From 1 Year Low (%) +50.29
Change From 1 Year High -21.595 % Change From 1 Year High (%) -38.82
2 Years Range 22.650 - 68.550 Change From 2 Years Low +11.390 % Change From 2 Years Low (%) +50.29
Change From 2 Years High -34.510 % Change From 2 Years High (%) -50.34
5 Years Range 14.380 - 68.550 Change From 5 Years Low +19.660 % Change From 5 Years Low (%) +136.72
Change From 5 Years High -34.510 % Change From 5 Years High (%) -50.34
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Apr 2020 32.310 34.100 32.120 34.040 594,870 -
01 Apr 2020 33.210 34.710 32.410 32.790 583,492 -
31 Mar 2020 34.650 35.340 33.385 34.750 638,074 -
30 Mar 2020 33.220 35.400 31.850 35.030 710,308 -
27 Mar 2020 32.690 34.780 30.575 33.470 746,041 -
26 Mar 2020 31.920 34.080 31.170 33.820 838,342 -
25 Mar 2020 30.160 32.480 29.350 31.550 974,077 -
24 Mar 2020 27.870 30.630 27.756 30.040 862,544 -
23 Mar 2020 25.480 27.390 24.540 26.730 894,552 -
20 Mar 2020 26.480 27.810 24.790 24.870 1,237,089 -
19 Mar 2020 23.000 26.700 22.650 26.210 977,271 -
18 Mar 2020 24.800 26.570 22.750 23.300 1,229,731 -
17 Mar 2020 24.440 26.990 24.440 26.410 1,395,444 -
16 Mar 2020 26.360 29.970 23.880 23.990 1,342,846 -
13 Mar 2020 32.570 33.360 28.500 31.570 1,057,146 -
12 Mar 2020 33.150 34.320 30.390 31.040 1,298,528 -
11 Mar 2020 37.010 38.080 34.840 35.500 720,787 -
10 Mar 2020 38.020 38.430 35.350 37.890 667,205 -
09 Mar 2020 36.550 38.340 35.630 36.750 936,831 -
06 Mar 2020 38.880 41.380 38.670 39.710 578,126 -
05 Mar 2020 40.640 41.260 39.460 40.190 699,656 -
04 Mar 2020 40.320 42.680 39.990 41.910 835,145 -
Summary
Current 2 Weeks
(20 Mar 2020 to 02 Apr 2020)
26.480 35.400 24.540 34.040 8,079,389 -
Previous 2 Weeks
(06 Mar 2020 to 19 Mar 2020)
38.880 41.380 24.540 26.210 10,203,915 -
4 Weeks from
(06 Feb 2020 to 05 Mar 2020)
46.200 46.510 24.540 40.190 12,729,284 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.